SLC16A3 and cancer: Intercellular lactate shuttling is facilitated by monocarboxylate transporters (MCTs), with MCT1 and MCT4 being the most extensively studied and frequently overexpressed in cancer cells, emerging as promising therapeutic targets for cancer treatment [24].